Comparaison therapiutic effects of congugated linoleic acid with placebo in moderate females acne

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT201302164310N7

Enrollment

Registered

2014-04-28

Start date

2014-04-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris. L70.0 Acne vulgaris

Interventions

Intervention 1: Intervention group, was received doxycycline, 100 mg/day along 6 gr/day oral congugated linoleic acid for 30 days. Intervention 2: control group was received doxycycline 100 mg/day alo

Treatment - Drugs

Intervention group, was received doxycycline, 100 mg/day along 6 gr/day oral congugated linoleic acid for 30 days.

control group was received doxycycline 100 mg/day along 6 gr/day oral parafine ( placebo) for 30 days.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria :Females that have moderate acne. Exclusion criteria :pregnancy; breastfeeding; receiving anti acne drugs; ocp pills; and spironolacton in last 2 months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Decrease in acne lesions. Timepoint: one month. Method of measurement: lesions counting.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGolmohammadi Ghasem

Ardabil University of Medical Science

m.golmohammadi@arums.ac.ir+98 45 1551 0060

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026